Avenue Therapeutics | 8-K: Current report
May 2 04:34
Avenue Therapeutics | 8-K: Current report
Apr 27 04:45
Avenue Therapeutics | 8-K: Current report
Mar 30 02:43
Avenue Therapeutics | DEF 14C: Definitive information statements
Mar 19 05:01
Avenue Therapeutics | 8-K: Current report
Mar 19 04:16
Avenue Therapeutics | 8-K: Current report
Mar 15 19:20
Avenue Therapeutics | 8-K: Current report
Mar 9 05:19
Avenue Therapeutics | 8-K: Current report
Feb 24 05:25
Avenue Therapeutics | DEF 14C: Definitive information statements
Jan 29 21:03
Avenue Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Jan 25 05:15
Avenue Therapeutics | 8-K: Current report
Jan 12 13:00
Avenue Therapeutics | 8-K: Current report
Jan 8 13:00
Avenue Therapeutics | 8-K: Current report
Nov 25, 2023 02:19
Avenue Therapeutics | 8-K: Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
Nov 14, 2023 05:10
Avenue Therapeutics | 8-K: Current report
Nov 3, 2023 04:10
Avenue Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Oct 24, 2023 08:50
Avenue Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Sep 30, 2023 05:23
Avenue Therapeutics | 8-K: Current report
Sep 29, 2023 04:25
Avenue Therapeutics | 8-K: Current report
Sep 28, 2023 04:03
Avenue Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Sep 19, 2023 05:18
No Data
No Data